1. Research Progress of TXNIP as a Tumor Suppressor Gene Participating in the Metabolic Reprogramming and Oxidative Stress of Cancer Cells in Various Cancers
   Yiting Chen et al, 2020, Frontiers in Oncology CrossRef
2. The role of metabolic reprogramming in pancreatic cancer chemoresistance
   Chang Liu et al, 2023, Frontiers in Pharmacology CrossRef
3. One-shot dual gene editing for drug-resistant pancreatic cancer therapy
   Eun-Jeong Won et al, 2021, Biomaterials CrossRef
4. Inhibition of Autophagy Does Not Re-Sensitize Acute Myeloid Leukemia Cells Resistant to Cytarabine
   Nienke Visser et al, 2021, International Journal of Molecular Sciences CrossRef
5. Nuclear receptor coactivator 6 (NCoA6) promotes cell proliferation, migration, and invasion in pancreatic cancer
   Xin Wang et al, 2023, Cancer Medicine CrossRef
6. Role of hepatocyte nuclear factor 4 alpha in cell proliferation and gemcitabine resistance in pancreatic adenocarcinoma
   Qiqing Sun et al, 2019, Cancer Cell International CrossRef
7. Oncogenic function of TRIM2 in pancreatic cancer by activating ROS-related NRF2/ITGB7/FAK axis
   Qiqing Sun et al, 2020, Oncogene CrossRef
8. hENT1 reverses chemoresistance by regulating glycolysis in pancreatic cancer
   Yun Xi et al, 2020, Cancer Letters CrossRef
9. Regulation of metabolic reprogramming by tumor suppressor genes in pancreatic cancer
   Mengqi Liu et al, 2020, Experimental Hematology & Oncology CrossRef
10. Nucleoside transporters and immunosuppressive adenosine signaling in the tumor microenvironment: Potential therapeutic opportunities
    Tejinder Kaur et al, 2022, Pharmacology & Therapeutics CrossRef
11. Emerging roles of F-box proteins in cancer drug resistance
    Linzhi Yan et al, 2020, Drug Resistance Updates CrossRef
12. FBW7-NRA41-SCD1 axis synchronously regulates apoptosis and ferroptosis in pancreatic cancer cells
    Zeng Ye et al, 2021, Redox Biology CrossRef
13. MTAP Deficiency–Induced Metabolic Reprogramming Creates a Vulnerability to Cotargeting De Novo Purine Synthesis and Glycolysis in Pancreatic Cancer
    Qiangsheng Hu et al, 2021, Cancer Research CrossRef
14. Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy
    Kazuhiro Koikawa et al, 2021, Cell CrossRef
15. Therapeutic resistance of pancreatic cancer: Roadmap to its reversal
    Sen Yu et al, 2021, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
16. E3 Ubiquitin Ligase in Anticancer Drugdsla Resistance: Recent Advances and Future Potential
    Yuanqi Liu et al, 2021, Frontiers in Pharmacology CrossRef
17. PDLIM1 interacts with HK2 to promote gastric cancer progression through enhancing the Warburg effect via Wnt/β-catenin signaling
    Yunpeng Lei et al, 2024, Cell and Tissue Research CrossRef
18. Recent insight into the role of FBXW7 as a tumor suppressor
    Kanae Yumimoto et al, 2020, Seminars in Cancer Biology CrossRef
19. Role of Damage DNA-Binding Protein 1 in Pancreatic Cancer Progression and Chemoresistance
    Yiyin Zhang et al, 2019, Cancers CrossRef
20. microRNAs Associated with Gemcitabine Resistance via EMT, TME, and Drug Metabolism in Pancreatic Cancer
    Naotake Funamizu et al, 2023, Cancers CrossRef
21. F‑box/WD‑40 repeat‑containing protein 7: A potential target in the progression and treatment of gastrointestinal malignancy (Review)
    Yizhi Wang et al, 2019, Oncology Letters CrossRef
22. FBXW7 in Cancer: What Has Been Unraveled Thus Far?
    Bethsebie Lalduhsaki Sailo et al, 2019, Cancers CrossRef